Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $29,658 - $36,510
200 Added 13.33%
1,700 $252,000
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $545,895 - $700,315
-3,500 Reduced 70.0%
1,500 $258,000
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $689,282 - $889,314
3,800 Added 316.67%
5,000 $943,000
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $1.92 Million - $2.45 Million
-9,900 Reduced 89.19%
1,200 $293,000
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $170,361 - $188,721
900 Added 8.82%
11,100 $2.16 Million
Q2 2021

Aug 16, 2021

SELL
$155.9 - $187.99 $31,180 - $37,598
-200 Reduced 1.92%
10,200 $1.9 Million
Q1 2021

May 17, 2021

BUY
$144.0 - $169.39 $1.17 Million - $1.37 Million
8,100 Added 352.17%
10,400 $1.64 Million
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $361,261 - $401,005
2,300 New
2,300 $381,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.